Hyperbilirubinemia Final Paper
Hyperbilirubinemia Final Paper
Hyperbilirubinemia Final Paper
Shelby Robison
Jackson College
Abstract
This paper will help you understand more about hyperbilirubinemia and how it effects the
newborn baby. Hyperbilirubinemia continues to be one of the main concerns when caring for
newborns and has multiple causes. Long term effects are rare due to our highly effective
treatment options. All infants, especially pre-term, are at risk for developing hyperbilirubinemia.
Assessments of the skin will be made routinely, along with total serum bilirubin levels.
Screening is done on all infants in the hospital after birth. Our treatments have advanced
Hyperbilirubinemia presents as jaundice skin and is a common concern when caring for
neonates. Elevated bilirubin levels are present and are considered to be physiological or non-
hyperbilirubinemia and is not present during the first 24 hours of life but appears two to three
days after birth. (McKinney, James, Murray, Nelson, & Ashwill, 2018, p. 432) Non-physiological
jaundice can be seen within the first 24 hours and is caused by destruction of red blood cells or
problems with bilirubin conjugation. Infants, especially preterm, have a higher rate of bilirubin
production than adults because their red blood cell life span is shorter. Unconjugated bilirubin is
not readily excreted, and the ability to conjugate bilirubin is limited. (Dennery, Seidman, &
Stevenson, 2001)
The most common cause of pathologic jaundice is hemolytic disease which results from
blood incompatibility between the mother and the fetus, also known as Rh incompatibility. An
Rh-negative mother forms antibodies when Rh-positive blood from the fetus enters her
transfusion of Rh-positive blood. The antibodies can cross the placenta and destroy the fetal red
blood cells, causing erythroblastosis fetalis, a condition caused by agglutination and hemolysis of
fetal erythrocytes. (McKinney, James, Murray, Nelson, & Ashwill, 2018, p. 645) RhoGAM is a
Rho globulin that is given to the mother and inhibits the production of Rh-positive antibodies to
prevent erythroblastosis fetalis. ABO incompatibly also causes pathologic jaundice. Mothers
with type O blood have natural antibodies to types A and B blood. Hemolysis can occur when
these antibodies cross the placenta, but the destruction is much less severe than with Rh
condition caused by bilirubin toxicity. Kernicterus can also occur which is chronic and/or
permanent with effects of bilirubin toxicity. In kernicterus bilirubin stains the brain a yellow
color, specifically the basal ganglia, cerebellum, hippocampus, and brainstem. (McKinney,
James, Murray, Nelson, & Ashwill, 2018, p. 645) The mortality and morbidity rate of kernicterus
and bilirubin encephalopathy is high, but both of these conditions are rare. Long term
consequences when somebody survives these conditions are cerebral palsy, intellectual
phototherapy will rapidly reduce serum bilirubin. (Dennery, Seidman, & Stevenson, 2001) The
bilirubin in the skin is absorbed by the light and converts into water-soluble products called
lumirubin. Lumirubin does not require conjugation by the liver and can be excreted in the bile
and urine. Exchange transfusions are only used when phototherapy cannot reduce high bilirubin
levels. Small portions of blood are removed and replaced with an equal amount of donor blood.
At the end of the procedure, roughly 85% of the red blood cells have been replaced. (McKinney,
The nurse should assess the infant’s level of jaundice at least every 8 hours by pressing
over a bony prominence and noting the color. This assessment should be done when
phototherapy lights are off. Other important nursing interventions include maintaining a neutral
thermal environment, providing optimal nutrition, protecting the eyes, enhancing response to
therapy, detecting complications, and teaching parents. (McKinney, James, Murray, Nelson, &
Ashwill, 2018, p. 646) New parents will have lots of questions, so education is the key for the
nurse!
HYPERBILIRUBINEMIA 5
References
Dennery, P. A., Seidman, D. S., & Stevenson, D. K. (2001, February 22). Neonatal
https://www.nejm.org/doi/full/10.1056/NEJM200102223440807
McKinney, E. S., James, S. R., Murray, S. S., Nelson, K. A., & Ashwill, J. W.